AwardedHungaryServices
21 génes genomikai vizsg. (Oncotype DX) végzése
- Published
- Published 23 April 2026
- Deadline
- Closed 26 May 2026
Overview
Semmelweis University has awarded a contract to Med Gen-Sol Korlátolt Felelősségű Társaság for performing 21-gene genomic testing (Oncotype DX) for early breast cancer patients with HER2 positive, HER2 negative, and hormone receptor positive status. The scope includes sample transport, test performance, result evaluation, recurrence score reporting, receptor validation, and physician consultation, with 200 tests planned over 36 months for a total value of 111.8 million HUF.
Key details
- Country
- Hungary
- Status
- Awarded
- Category
- Services
- Procedure
- Open
- SME suitable
- Yes
- Published
- 23 April 2026
- Deadline
- Closed
Medical practice and related services
Award outcome
- Awarded value
- HUF 111,800,000
- Award date
- 11 June 2026
- Contract period
- — → 26 May 2029
- Med Gen-Sol Korlátolt Felelősségű Társaság
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 June 2026
Contract Notice
23 April 2026
Contracting authority
Semmelweis Egyetem
Procuring entityBudapest, Hungary
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.